![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SANDOZ APPROVAL COULD OPEN THE FLOODGATES FOR BIOSIMILARS IN US
SANDOZ APPROVAL COULD OPEN THE FLOODGATES FOR BIOSIMILARS IN US
June 5, 2006
German biopharma firm Sandoz has won a landmark first-of its-kind biosimilar drug approval in the US after a long battle with the Food and Drug Administration (FDA). The decision could open the floodgates for generics manufacturers in this lucrative market.
In-PharmaTechnologist.com (http://www.in-pharmatechnologist.com/news/ng.asp?n=68163-sandoz-fda-biosimilar-omnitrope-follow-on-protein)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct